Koers Fujian Cosunter Pharmaceutical Co., Ltd.
Aandelen
300436
CNE100001YZ0
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18,68 CNY | -0,27% | -8,88% | -27,12% |
Omzet 2021 | 370 mln. 51,25 mln. 47,44 mln. | Omzet 2022 | 386 mln. 53,37 mln. 49,4 mln. | Marktkapitalisatie | 6,24 mld. 863 mln. 799 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -34 mln. -4,7 mln. -4,35 mln. | Nettowinst (verlies) 2022 | -127 mln. -17,57 mln. -16,26 mln. | EV/omzet 2021 | 20 x |
Nettoliquiditeiten 2021 | 206 mln. 28,54 mln. 26,41 mln. | Nettoschuld 2022 | 72,57 mln. 10,04 mln. 9,29 mln. | EV/omzet 2022 | 16,4 x |
K/w-verhouding 2021 |
-206
x | K/w-verhouding 2022 |
-48,9
x | Werknemers | 908 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 50,74% |
1 dag | -0,16% | ||
1 week | -8,63% | ||
Lopende maand | -4,88% | ||
1 maand | -10,00% | ||
3 maanden | -24,66% | ||
6 maanden | -30,27% | ||
Lopend jaar | -26,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 28-06-01 |
Jian Hui Guan
DFI | Director of Finance/CFO | 48 | 25-07-17 |
Yuan Li Li
CHM | Chairman | 66 | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 28-06-01 |
Li Qing Ye
BRD | Director/Board Member | 54 | 20-09-11 |
Guo Dong Li
BRD | Director/Board Member | 53 | 01-01-02 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 18,68 | -0,27% | 1 826 757 |
27-03-24 | 18,73 | -0,16% | 1 662 500 |
26-03-24 | 18,76 | -0,90% | 1 804 400 |
25-03-24 | 18,93 | -4,44% | 2 134 820 |
22-03-24 | 19,81 | -2,12% | 1 885 800 |
slotkoers Shenzhen S.E., 27 maart 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,92% | 413 mln. | |
+33,85% | 701 mld. | |
+26,24% | 571 mld. | |
+1,17% | 381 mld. | |
+20,85% | 334 mld. | |
+16,35% | 319 mld. | |
+1,13% | 210 mld. | |
+2,59% | 210 mld. | |
-6,67% | 201 mld. | |
-3,18% | 157 mld. |